Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miroslaw Lech is active.

Publication


Featured researches published by Miroslaw Lech.


Nature Medicine | 1999

TARGETED DISRUPTION OF CD39/ATP DIPHOSPHOHYDROLASE RESULTS IN DISORDERED HEMOSTASIS AND THROMBOREGULATION

Keiichi Enjyoji; Jean Sévigny; Yuan Lin; Paul S. Frenette; Patricia D. Christie; Jan Schulte am Esch; Masato Imai; Jay M. Edelberg; Helen Rayburn; Miroslaw Lech; David Beeler; Eva Csizmadia; Denisa D. Wagner; Simon C. Robson; Robert D. Rosenberg

CD39, or vascular adenosine triphosphate diphosphohydrolase, has been considered an important inhibitor of platelet activation. Unexpectedly, cd39-deficient mice had prolonged bleeding times with minimally perturbed coagulation parameters. Platelet interactions with injured mesenteric vasculature were considerably reduced in vivo and purified mutant platelets failed to aggregate to standard agonists in vitro. This platelet hypofunction was reversible and associated with purinergic type P2Y1 receptor desensitization. In keeping with deficient vascular protective mechanisms, fibrin deposition was found at multiple organ sites in cd39-deficient mice and in transplanted cardiac grafts. Our data indicate a dual role for adenosine triphosphate diphosphohydrolase in modulating hemostasis and thrombotic reactions.


Nature Biotechnology | 2003

Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide

Balagurunathan Kuberan; Miroslaw Lech; David Beeler; Zhengliang L. Wu; Robert D. Rosenberg

Heparan sulfate (HS) proteoglycans are crucial to numerous biological processes and pathological conditions, but to date only a few HS structures have been synthesized and characterized with regard to structure-function relationships. Because HS proteoglycans are highly diverse in structure, there are substantial limitations on their synthesis by classical chemical means, and thus new methods to rapidly assemble bioactive HS structures are needed. Here we report the biosynthesis of bioactive HS oligosaccharides using an engineered set of cloned enzymes that mimics the Golgi apparatus in vitro. We rapidly and efficiently assembled the antithrombin III–binding pentasaccharide in just 6 steps, in contrast to the approximately 60 steps needed for its chemical synthesis, with an overall yield at least twofold greater and a completion time at least 100 times faster than for the chemical process.


Journal of Biological Chemistry | 2003

Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides

Balagurunathan Kuberan; David Beeler; Miroslaw Lech; Zhengliang L. Wu; Robert D. Rosenberg

Heparan sulfate (HS) polysaccharides interact with numerous proteins at the cell surface and orchestrate many different biological functions. Though many functions of HS are well established, only a few specific structures can be attributed to HS functions. The extreme diversity of HS makes chemical synthesis of specific bioactive HS structures a cumbersome and tedious undertaking that requires laborious and careful functional group manipulations. Now that many of the enzymes involved in HS biosynthesis are characterized, we show in this study how one can rapidly and easily assemble bioactive HS structures with a set of cloned enzymes. We have demonstrated the feasibility of this new approach to rapidly assemble antithrombin III-binding classical and non-classical anticoagulant polysaccharide structures for the first time.


Journal of Biological Chemistry | 2005

Characterizing the non-reducing end structure of heparan sulfate

Zhengliang L. Wu; Miroslaw Lech

The reducing end of heparan sulfate has been known for a long time, but information on the non-reducing end has been lacking. Recent studies indicate that the non-reducing end of heparan sulfate might be the place where fibroblast growth factor signaling complex forms. The non-reducing end also changes with heparanase digestion and, thus, might serve as a marker for tumor pathology. Using high performance liquid chromatography-coupled mass spectrometry, we have identified and characterized the non-reducing end of bovine kidney heparan sulfate. We find that the non-reducing end region is highly sulfated and starts with a glucuronic acid (GlcA) residue. The likely sequence of the non-reducing end hexasaccharides is GlcA-GlcNS6S-UA±2S-GlcNS±6S-Ido2S-GlcNS±6S (where GlcNS is N-sulfate-d-glucosamine, S is sulfate, UA is uronic acid, and Ido is iduronic acid). Our data suggests that the non-reducing end of bovine kidney heparan sulfate is not trimmed by heparanase and is capable of supporting fibroblast growth factor signaling complex formation.


Journal of Biological Chemistry | 2004

Determining Heparan Sulfate Structure in the Vicinity of Specific Sulfotransferase Recognition Sites by Mass Spectrometry

Zhengliang L. Wu; Miroslaw Lech; David Beeler; Robert D. Rosenberg

Sulfated motifs on heparan sulfate (HS) are involved in various extracellular processes from cell signaling to enzymatic regulation, but the structures of these motifs are obscure. We have developed a strategy to determine the structure of sulfotransferase recognition sites which constitute these motifs. Stable isotope is first introduced into specific sites on HS with HS sulfotransferases and the modified HS is then digested into oligosaccharides of differing sizes. The overlapping oligosaccharides containing the introduced stable isotope are identified by changes in the m/z profiles by mass spectrometry, and their relationships are elucidated. In this way, the HS structures in the vicinity of the sulfotransferase recognition site are quickly determined and groups on precursor structures of HS that direct the action of HS sulfotransferases are pinpointed.


Journal of Biological Chemistry | 2004

Light-induced 3-O-Sulfotransferase Expression Alters Pineal Heparan Sulfate Fine Structure A SURPRISING LINK TO CIRCADIAN RHYTHM

Balagurunathan Kuberan; Miroslaw Lech; Jimo Borjigin; Robert D. Rosenberg

Proteoglycans are dominant glycoconjugates located on the cell surface and in extracellular spaces and consist of a core protein with one or more glycosaminoglycan side chains linked covalently. Heparan sulfate (HS) belongs to the family of glycosaminoglycans. HS has been assigned a variety of physiological and pathological functions, such as cell-cell adhesion, cell-matrix adhesion, cell proliferation, motility and differentiation, lipoprotein metabolism, blood coagulation, inflammation, tissue regeneration, tumor progression and invasion, pathogenic infection by bacteria, protozoa, and viruses, through specific interaction with a wide array of proteins, ligands, receptors, and pathogens (Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Annu. Rev. Biochem. 68, 729–777). We have shown here for the first time that light induces changes in pineal HS fine structure and that occurrence of the rare 3-O sulfation catalyzed by HS 3-O-sulfotransferase (3-OST2) is predominantly restricted to daytime pineal glands.


Biochemical Journal | 2005

Modification degrees at specific sites on heparan sulphate: an approach to measure chemical modifications on biological molecules with stable isotope labelling

Zhengliang L. Wu; Miroslaw Lech

Chemical modification of biological molecules is a general mechanism for cellular regulation. A quantitative approach has been developed to measure the extent of modification on HS (heparan sulphates). Sulphation on HS by sulphotransferases leads to variable sulphation levels, which allows cells to tune their affinities to various extracellular proteins, including growth factors. With stable isotope labelling and HPLC-coupled MS, modification degrees at various O-sulphation sites could be determined. A bovine kidney HS sample was first saturated in vitro with 34S by an OST (O-sulphotransferase), then digested with nitrous acid and analysed with HPLC-coupled MS. The 34S-labelled oligosaccharides were identified based on their unique isotope clusters. The modification degrees at the sulphotransferase recognition sites were obtained by calculating the intensities of isotopic peaks in the isotope clusters. The modification degrees at 3-OST-1 and 6-OST-1 sites were examined in detail. This approach can also be used to study other types of chemical modifications on biological molecules.


Glycoconjugate Journal | 2017

An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure

Daniela Beccati; Miroslaw Lech; Jennifer Ozug; Nur Sibel Gunay; Jing Wang; Elaine Y. Sun; Joël R. Pradines; Victor Farutin; Zachary Shriver; Ganesh Kaundinya; Ishan Capila

Heparan sulfate (HS), a glycosaminoglycan present on the surface of cells, has been postulated to have important roles in driving both normal and pathological physiologies. The chemical structure and sulfation pattern (domain structure) of HS is believed to determine its biological function, to vary across tissue types, and to be modified in the context of disease. Characterization of HS requires isolation and purification of cell surface HS as a complex mixture. This process may introduce additional chemical modification of the native residues. In this study, we describe an approach towards thorough characterization of bovine kidney heparan sulfate (BKHS) that utilizes a variety of orthogonal analytical techniques (e.g. NMR, IP-RPHPLC, LC-MS). These techniques are applied to characterize this mixture at various levels including composition, fragment level, and overall chain properties. The combination of these techniques in many instances provides orthogonal views into the fine structure of HS, and in other instances provides overlapping / confirmatory information from different perspectives. Specifically, this approach enables quantitative determination of natural and modified saccharide residues in the HS chains, and identifies unusual structures. Analysis of partially digested HS chains allows for a better understanding of the domain structures within this mixture, and yields specific insights into the non-reducing end and reducing end structures of the chains. This approach outlines a useful framework that can be applied to elucidate HS structure and thereby provides means to advance understanding of its biological role and potential involvement in disease progression. In addition, the techniques described here can be applied to characterization of heparin from different sources.


Journal of the American Chemical Society | 2002

Analysis of Heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry

Balagurunathan Kuberan; Miroslaw Lech; Lijuan Zhang; Zhengliang L. Wu; David Beeler; Robert D. Rosenberg


Journal of Biological Chemistry | 2001

6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway

Lijuan Zhang; David Beeler; Roger Lawrence; Miroslaw Lech; Jian Liu; Joseph Davis; Zachary Shriver; Ram Sasisekharan; Robert D. Rosenberg

Collaboration


Dive into the Miroslaw Lech's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Beeler

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhengliang L. Wu

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Roger Lawrence

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ishan Capila

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Jian Liu

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Lijuan Zhang

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zachary Shriver

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge